Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells

Systemic lupus erythematosus (SLE) is an autoimmune disease with a broad range of clinical manifestations and a heterogeneous disease course. There is no cure for SLE, but current standard pharmacotherapies can improve disease prognosis in most patients. However, some patients are refractory to conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Lihui, Labopin, Myriam, Badoglio, Manuela, Wang, Dandan, Sun, Lingyun, Farge-Bancel, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525791/
https://www.ncbi.nlm.nih.gov/pubmed/31191681
http://dx.doi.org/10.1155/2019/7061408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525791/
https://www.ncbi.nlm.nih.gov/pubmed/31191681
http://dx.doi.org/10.1155/2019/7061408

Ejemplares similares